Eat to Live: The Amazing Nutrient-Rich Program for Fast and Sustained Weight Loss (57 page)

15
De Natale C, Annuzzi G, Bozzetto L, et al. Effects of a plant-based high-carbohydrate/high-fiber diet versus high-monounsaturated fat/low-carbohydrate diet on postprandial lipids in type 2 diabetic patients.
Diabetes Care.
2009 Dec;32(12):2168–73; Anderson JW. Dietary fiber prevents carbohydrate-induced hypertriglyceridemia.
Curr Atheroscler Rep.
2000 Nov;2(6):536–41; Turley ML, Skeaff CM, Mann JI, Cox B. The effect of low-fat, high-carbohydrate diet on serum high density lipoprotein cholesterol and triglycerides.
Eur J Clin Nutr.
1998; 52(10):728–32.

16
Jenkins DJ, Kendall CW, Popovich DG. Effects of a very-high-fiber vegetable, fruit, and nut diet on serum lipids and colonic function.
Metabolism.
2001;50 (4): 494–503.

17
Lichtenstein AH, Van Horn L. Very low fat diets.
Circulation.
1998 Sep 1;98(9):935–39.

18
Ivanov AN, Medkova IL, Mosiakina LI. The effect of anti-atherogenic vegetarian diet on the clinico-hemodynamic and biochemical indices in elderly patients with ischemic heart disease.
Ter Arkh.
1999;71(2):75–78.

19
Ishikawa T. Postprandial lipemia as an atherosclerotic risk factor and fat tolerance test.
Nippon Rinsho
1999;57(12):2668–72.

20
Koeford BC, Gullov AL, Peterson P. Cerebral complications of surgery using cardiopulmonary bypass.
Ugeskr Laeger.
1995;157(6)728–34.

21
Joshi B, Brady K, Lee J, et al. Impaired autoregulation of cerebral blood flow during rewarming from hypothermic cardiopulmonary bypass and its potential association with stroke.
Anesth Analg.
2010 Feb;110(2):321–28; Chauhan S. Brain, cardiopulmonary bypass and temperature: what should we be doing?
Ann Card Anaesth.
2009 Jul–Dec;12(2):104–6; Brain damage and open-heart surgery.
Lancet.
1989 Aug 12; 2(8659):364–66.

22
Hanekamp C, Koolen J, Bonnier H, et al. Randomized comparison of balloon angioplasty versus silicon carbon-coated stent implantation for de novo lesions in small coronary arteries.
Am J Cardiol.
2004 May 15;93(10):1233–37.

23
Agostoni P, Valgimigli M, Biondi-Zoccai GG, et al. Clinical effectiveness of bare-metal stenting compared with balloon angioplasty in total coronary occlusions: insights from a systematic overview of randomized trials in light of the drug-eluting stent era.
Am Heart J.
2006 Mar;151(3): 682–89.

24
Stähli BE, Camici GG, Tanner FC. Drug-eluting stent thrombosis.
Ther Adv Cardiovasc Dis.
2009 Feb;3(1):45–52; Lüscher TF, Steffel J, Eberli FR, et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications.
Circulation.
2007 Feb 27;115(8):1051–58.

25
Bates B. Angiograms miss most atheromas.
Family Practice News.
2001 Jul 15;31(14):1, 4.

26
Nissen SE. Pathobiology, not angiography, should guide management in acute coronary syndrome/non-ST-segment elevation myocardial infarction: the non-interventionist’s perspective.
J Am Coll Cardiol.
2003 Feb 19;41(4) (suppl S):S103–12; Schoenhagen P, Ziada KM, Vince DG, Nissen SE, Tuzcu EM. Arterial remodeling and coronary artery disease: the concept of “dilated” versus “obstructive” coronary atherosclerosis.
J Am Coll Cardiol.
2001 Aug;38(2)297–306.

27
Shrihari JS, Roy A, Prabhakaran D, Reddy KS. Role of EDTA chelation therapy in cardiovascular diseases.
Natl Med J India.
2006 Jan–Feb;19(1):24–26; Seely DM, Wu P, Mills EJ. EDTA chelation therapy for cardiovascular disease: a systematic review.
BMC Cardiovasc Disord.
2005 Nov 1;5:32.

28
Gould KL. New concepts and paradigms in cardiovascular medicine: the noninvasive management of coronary artery disease.
Am J Med.
1998;104(6A)(suppl):S2–17; Franklin BA, Kahn JK. Delayed progression or regression of coronary atherosclerosis with intensive risk factor modification: effects of diet, drugs, and exercise.
Sports Med.
1996;22(5):306–20.

29
Kannel WB. Range of serum cholesterol values in the population developing coronary artery disease.
Am J Cardiol.
1995;76(9): 69c–77c; Castelli WP, Anderson K, Wilson PW, Levy D. Lipids and the risk of coronary heart disease: the Framingham Study.
Ann Epidemiol.
1992;2(1–2):23–28.

30
Cooper R, Rotimi C, Ataman S, et al. The prevalence of hypertension in seven populations of west African origin.
Am J Public Health.
1997 Feb;87(2):160–8. He J, Klag MJ, Whelton PK, et al. Body mass and blood pressure in a lean population in southwestern China.
Am J Epidemiol.
1994 Feb 15;139(4):380–9.

31
Fogari R, Zoppi A, Corradi L, et al. Effect of body weight loss and normalization on blood pressure in overweight non-obese patients with stage 1 hypertension.
Hypertens Res.
2010 Mar;33(3):236–42; Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet.
N Eng J Med.
2001 Jan 4;344(1):3–10; Haddy FJ, Vanhoutte PM, Feletou M. Role of potassium in regulating blood flow and blood pressure.
Am J Physiol Regul Integr Comp Physiol.
2006 Mar;290(3):R546–52; Wu G, Tian H, Han K, et al. Potassium magnesium supplementation for four weeks improves small distal artery compliance and reduces blood pressure in patients with essential hypertension.
Clin Exp Hypertens.
2006 Jul;28(5): 489–97; Houston MC, Harper KJ. Potassium, magnesium, and calcium: their role in both the cause and treatment of hypertension.
J Clin Hypertens (Greenwich).
2008 Jul;10(7)(suppl) 2):S3–11; Sesso HD, Cook NR, Buring JE, et al. Alcohol consumption and the risk of hypertension in women and men.
Hypertension.
2008 Apr; 51(4):1080–7; Beilin LJ, Puddey IB. Alcohol and hypertension: an update.
Hypertension.
2006 Jun; 47(6):1035–38; Uiterwaal CS, Verschuren WM, Bueno-de-Mesquita HB, et al. Coffee intake and incidence of hypertension.
Am J Clin Nutr.
2007 Mar;85(3):718–23; Winkelmayer WC, Stampfer MJ, Willett WC, et al. Habitual caffeine intake and the risk of hypertension in women.
JAMA.
2005 Nov 9;294(18):2330–35; Flint AJ, Hu FB, Glynn RJ, et al. Whole grains and incident hypertension in men.
Am J Clin Nutr.
2009 Sep;90(3):493–98; Utsugi MT, Ohkubo T, Kikuya M, et al. Fruit and vegetable consumption and the risk of hypertension determined by self measurement of blood pressure at home: the Ohasama study.
Hypertens Res.
2008 Jul;31(7):1435–43; Owen A, Wiles J, Swaine I. Effect of isometric exercise on resting blood pressure: a meta analysis.
J Hum Hypertens.
2010 Feb 25. [Epub ahead of print]; Chen YL, Liu YF, Huang CY, et al. Normalization effect of sports training on blood pressure in hypertensives.
J Sports Sci.
2010 Feb;19:1–7.

32
Jablonski KL, Gates PE, Pierce GL, Seals DR. Low dietary sodium intake is associated with enhanced vascular endothelial function in middle-aged and older adults with elevated systolic blood pressure.
Ther Adv Cardiovasc Dis.
2009 Oct;3(5): 347–56; Padiyar A. Nonpharmacologic management of hypertension in the elderly.
Clin Geriatr Med.
2009 May;25(2):213–19; Whelton PK, Appel LI, Espeland MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly.
JAMA.
1998;279:839–46.

33
Stafford RS, Blumenthal D. Specialty differences in cardiovascular disease prevention practices.
J Am Coll Cardiol.
1998; 32(5): 1238–43.

34
American Diabetes Association: Diabetes Statistics.
http://www.diabetes.org/diabetes-basics/diabetes-statistics
.

35
American Diabetes Association. Diabetes Statistics.
http://www.diabetes.org/diabetes-basics/diabetes-statistics/
.

36
Eppens MC, Craig ME, Cusumano J, et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes.
Diabetes Care.
2006. Jun 29:1300–6; Gaster B, Hirsh IB. The effects of improved glucose control on complications in type 2 diabetes.
Arch Intern Med.
1998; 158:34–40.

37
Ioacara S, Lichiardopol R, Ionescu-Tirgoviste C, et al. Improvements in life expectancy in type 1 diabetes patients in the last six decades.
Diabetes Res Clin Pract.
2009 Nov;86(2):146–51; Barr EL, Zimmet PZ, Welborn TA, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
Circulation.
2007 Jul 10;116(2):151–57; Siscovick DS, Sotoodehnia N, Rea TD, et al. Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community.
Rev Endocr Metab Disord.
2010 Mar;11(1):53–59; Stamler J, Stamler O, Vaccaro JD. Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the multiple risk factor intervention trial.
Diabetes Care.
1993;16:434–44; Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.
N Eng J Med.
1998;339(4):229–34; Janka HU. Increased cardiovascular morbidity and mortality in diabetes mellitus: identification of the high risk patient.
Diabetes Res Clin Pract.
1996;30(suppl):585–88.

38
Crane M. Regression of diabetic neuropathy with total vegetarian (vegan) diet.
J Nutr Med.
1994; 4:431.

39
Rector RS, Warner SO, Liu Y, et al. Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome.
Am J Physiol Endocrinol Metab.
2007 Aug;293(2):E500–6; Dengel DR, Kelly AS, Olson TP, et al. Effects of weight loss on insulin sensitivity and arterial stiffness in overweight adults.
Metabolism.
2006 Jul;55(7):907–11; Rosenfalck AM, Almdal T, Viggers L, et al. A low-fat diet improves peripheral insulin sensitivity in patients with type 1 diabetes.
Diabetic Med.
2006 Apr;23(4):384–92.

40
Williamson DF, Thompson TJ, Thun M, et al. Intentional weight loss and mortality among overweight individuals with diabetes.
Diabetes Care.
2000;23(10): 1499–1504; Fujioka K. Benefits of moderate weight loss in patients with type 2 diabetes.
Diabetes Obes Metab.
2010 Mar;12(3):186–94.

41
Hinton EC, Parkinson JA, Holland AJ, Arana FS, Roberts AC, Owen AM. Neural contributions to the motivational control of appetite in humans.
Eur J Neurosci.
2004 Sep;20(5):1411–18; Tataranni, PA, Gautier JF, Chen K, et al. Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography.
Proc Natl Acad Sci. U S A.
1999;96(8): 4569–74; Friedman MI, Ulrich P, Mattes RD. A figurative measure of subjective hunger sensations.
Appetite
1999;32(3):395–404.

42
Fukui PT, Gonçalves TR, Strabelli CG, et al. Trigger factors in migraine patients.
Arq Neuropsiquiatr.
2008 Sep;66(3A):494–99; Millichap JG, Yee MM. The diet factor in pediatric and adolescent migraine.
Pediatr Neurol.
2003 Jan;28(1):9–15; Diamond S. Migraine headache: recognizing its peculiarities, precipitants, and prodromes.
Consultant.
1995 Aug; 1190–95.

43
Fuhrman, J.
Fasting and eating for health: a medical doctor’s program for conquering disease.
New York: St. Martin’s Press; 1995.

44
Katsarava Z, Holle D, Diener HC. Medication overuse headache.
Curr Neurol Neurosci Rep.
2009 Mar;9(2):115–19; Stephenson, J. Detox is crucial in chronic daily headache.
Family Practice News.
1993 Jul:1, 2.

45
Hagen KB, Byfuglien MG, Falzon L, et al. Dietary interventions for rheumatoid arthritis.
Cochrane Database Syst Rev.
2009 Jan 21; (1):CD006400; Proudman SM, Cleland LG, James MJ. Dietary omega-3 fats for treatment of inflammatory joint disease: efficacy and utility.
Rheum Dis Clin North Am.
2008 May;34(2):469–79; Calder PC, Albers R, Antoine JM, et al. Inflammatory disease processes and interactions with nutrition.
Br J Nutr.
2009 May; 101(suppl 1):S1–45; O’Sullivan M. Symposium on “The challenge of translating nutrition research into public health nutrition.” Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on “Nutrition and autoimmune disease.” Nutrition in Crohn’s disease.
Proc Nutr Soc.
2009 May;68(2):127–34; Calder PC. Session 3: Joint Nutrition Society and Irish Nutrition and Dietetic Institute Symposium on “Nutrition and autoimmune disease.” PUFA, inflammatory processes and rheumatoid arthritis.
Proc Nutr Soc.
2008 Nov;67(4): 409–18; Fujita A, Hashimoto Y, Nakahara K, et al. Effects of a low-calorie vegan diet on disease activity and general condition in patients with rheumatoid arthritis.
Rinsho Byori
1999;47(6):554–60; Haugen MA, Kjeldsen-Kragh J, Bjerve KS, et al. Changes in plasma phospholipid fatty acids and their relationship to disease activity in rheumatoid arthritis patients treated with a vegetarian diet.
Br J Nutr.
1994;72(4):555–66; Peltonen R, Nenonen M, Helve T, et al. Faecal microbial flora and disease activity in rheumatoid arthritis during a vegan diet.
Br J Rheumatol.
1997; 36(1):64–68; Kjeldsen-Kragh J. Rheumatoid arthritis treated with vegetarian diets.
Am J Clin Nutr.
1999;70(suppl 3):S594–600; Haddad EH, Berk LS, Kettering JD, et al. Dietary intake and biochemical, hematologic, and immune status of vegans compared with nonvegetarians.
Am J Clin Nutr.
1999;70(suppl 3): S586–93.